Saatvik Green Energy Limited announces a new order win

As of 1 September 2026, the 2.4 GW Odisha cell facility had not yet reached full-scale commercial production. The plant was in the final installation, testing, validation and process-readiness phase; the cell line was expected to begin ramp-up shortly. The dedicated 220 kV substation was ready for charging, but the facility was described as moving towards commissioning rather than already operating at commercial scale. ^[1]

Projected timeline:

• Near term: Cell-line ramp-up was expected to commence shortly, with ALMM List-II inspection planned for September 2026. ^[1]
• Full operationalisation: The company has not disclosed a firm date for when the entire 2.4 GW capacity will be fully operational.
• Revenue generation: No specific commercial-sales or revenue-start date has been provided. ALMM eligibility remains subject to MNRE approval and enlistment, which is required for participation in projects subject to domestic-sourcing requirements. ^[2]

The appropriate interpretation is therefore commissioning and initial ramp-up in the near term, followed by a non-dated progression toward full-scale commercialisation. The 2.4 GW should not yet be treated as an operating or fully revenue-generating capacity; the key milestones are successful ramp-up, ALMM inspection and enlistment, and subsequent customer offtake.

The reported Odisha project outlay is Rs 3,150 Crores, but the evidence supports this as an announced investment, not necessarily the amount already incurred. The 2.4 GW cell line is part of the broader Odisha manufacturing project, alongside a 4 GW module line. ^{[3] [4]}

Balance-sheet impact

The latest available consolidated figures, for Q1 FY27, show a clear increase in leverage versus Q2 FY26:

• Total debt: Rs 881.29 Crores versus Rs 528.57 Crores, an increase of Rs 352.72 Crores; non-current borrowings rose from nil to Rs 210.82 Crores, while current borrowings increased to Rs 670.47 Crores. ^{[5] [6] [7]}
• Net debt: Rs 853.39 Crores versus Rs 247.23 Crores, an increase of Rs 606.16 Crores. The larger rise in net debt reflects both higher borrowings and cash declining to Rs 27.90 Crores from Rs 281.34 Crores. ^{[8] [9]}
• Debt-to-equity: increased to 0.65x from 0.44x, while net debt-to-equity rose to 0.63x from 0.21x. ^{[10] [11]}
• Capital work in progress: increased to Rs 384.14 Crores from Rs 33.39 Crores, consistent with substantial ongoing project investment, although this balance is not separately identified as the 2.4 GW Odisha facility. ^[12]

Interest-cover effect

The investment phase coincides with weaker reported earnings coverage:

• Quarterly consolidated interest coverage: 1.96x in Q1 FY27, down from 7.52x in Q4 FY26. ^[13]
• TTM consolidated interest coverage: 5.11x, down from 7.26x at Q4 FY26. ^[14]
• Consolidated finance costs were up 14.1% YoY in Q1 FY27, while profit attributable to owners fell 95.4% YoY, creating operating pressure on coverage. ^{[15] [16]}

Implication: the Odisha build-out has materially increased the company’s funding requirement and reduced cash buffers, with leverage rising and near-term interest cover weakening sharply. However, the financial statements do not isolate debt raised or capex incurred specifically for the 2.4 GW facility. Therefore, Rs 3,150 Crores should be treated as the project’s announced outlay—not as verified cumulative spend—and the deterioration in debt and coverage cannot be attributed exclusively to that facility.

Verdict: The 2.4 GW Odisha cell line would move Saatvik from a predominantly module-led business toward a cell–module integrated model, improving control over a key input and enabling DCR/ALMM-linked projects. However, it would not yet make Saatvik the deepest-integrated listed player: Vikram Solar has disclosed a larger near-term cell rollout and a more advanced wafer-and-ingot roadmap. The gross-margin direction should be positive, but the company has not disclosed a quantified gross-margin uplift; management has guided only to broadly stable 12–13% EBITDA margins, with improvement expected once cell production contributes.^[17]

What changes for Saatvik

Saatvik currently operates 4.86 GW of module capacity and is developing an Odisha integrated project with planned 4 GW of module capacity and 6 GW of cell capacity.^[18] The 2.4 GW line is designed for high-efficiency N-TOPCon G12R cells under the DCR category, which would give Saatvik an internal source of cells for its own modules and a potential eligibility advantage in projects requiring domestic sourcing, subject to MNRE approval and ALMM List-II enlistment.^[2][2]

This is strategically more important than simply adding capacity:

• It reduces dependence on imported cells, including associated freight, currency and supply-timing exposure.
• It allows Saatvik to retain more of the cell-to-module value chain rather than capturing only module-assembly economics.
• It strengthens its ability to bid for DCR-compliant projects.
• It creates a platform for the next integration steps: management has discussed a further 3.6 GW cell Phase II and a planned 6 GW ingot-and-wafer Phase III targeted for FY29.^[19]

One qualification matters: the 1 September 2026 filing records the subsidiary’s application for ALMM List-II enlistment, while the earlier update described the cell line as moving toward ramp-up and commissioning. The strategic shift is therefore visible, but steady-state production, utilization and cell yields are not yet demonstrated in reported financials.^[2][1]

Peer positioning

Vikram Solar

Vikram is the closest like-for-like benchmark. It expects to commission 9 GW of cell capacity by December 2026, while expanding module capacity from 9.5 GW to 15.5 GW; its longer-term plan includes 12 GW of wafer and ingot capacity by FY29–30.^[20][21]

Implication: Saatvik moves decisively ahead of a pure module-assembly model, but Vikram currently has the larger disclosed cell scale and a more advanced full-value-chain roadmap.

Ram Ratna Wires

Ram Ratna Wires has a Q1 FY27 consolidated gross margin of 8.9%.^[22] No comparable solar-cell capacity or ALMM-II commissioning milestone is reported for the company, so it is not a like-for-like benchmark for upstream solar integration.

Shilchar Technologies

Shilchar reported a Q1 FY27 standalone gross margin of 30.5%.^[23] No comparable solar-cell manufacturing milestone is reported. Its standalone basis and business mix also make the margin unsuitable for direct comparison with Saatvik’s consolidated solar manufacturing economics.

Websol Energy System

Websol reported a Q1 FY27 consolidated gross margin of 51.2%.^[24] The cited disclosures do not establish a comparable 2.4 GW-scale cell integration milestone. Its reported gross margin should therefore not be interpreted as evidence of superior cell integration; product mix and accounting scope are different.

Ravindra Energy

Ravindra Energy reported a Q1 FY27 consolidated gross margin of 55.2%.^[25] No comparable solar-cell manufacturing commissioning milestone is reported. Its margin is not a direct peer benchmark for Saatvik’s cell-to-module manufacturing transition.

Gross-margin impact

Saatvik’s consolidated gross margin was 21.7% in Q1 FY27, versus a 20.4% TTM margin, providing the relevant pre-scale reference point.^[26][27] The likely bridge is:

• Positive: internally manufactured cells can replace purchased imported cells and allow Saatvik to capture cell conversion value, while lowering import-related logistics and currency exposure.
• Potentially material but unquantified: the benefit should increase with the proportion of modules using internally produced cells, plant utilization and manufacturing yield.
• Offsetting initially: cell manufacturing adds depreciation, power, labour, financing and start-up yield costs. In consolidated accounts, these costs remain within the group’s cost base; the entire imported-cell purchase price does not simply convert into gross profit.
• Competitive pass-through risk: if domestic cell supply becomes abundant or module pricing remains competitive, part of the cost saving may be passed to customers rather than retained as margin.

Management’s published expectation is therefore best read as an EBITDA recovery thesis, not a quantified gross-margin forecast: margins may soften temporarily, then improve once the cell line starts contributing, with full-year EBITDA margins expected to remain broadly around 12–13%.^[17] The key proof points will be internal-cell utilization, cell cost per watt versus landed import cost, yield ramp-up and whether consolidated gross margin expands without sacrificing module pricing.